EF
MED icon

Empowered Funds’s Medifast MED Stock Holding History

Empowered Funds’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$701K Sell
66,105
-5,479
-8% -$63.2K ﹤0.01% 1562
2026
Q1 		$729K Buy
71,584
+26,811
+60% +$289K ﹤0.01% 1519
2025
Q4 		$478K Buy
44,773
+4,462
+11% +$53.4K 0.01% 763
2025
Q3 		$551K Buy
40,311
+4,267
+12% +$59.6K 0.01% 1368
2025
Q2 		$506K Buy
+36,044
New +$474K 0.01% 1312
2021
Q3 		– Sell
-5,419
Closed -$1.53M – 258
2021
Q2 		$1.53M Buy
+5,419
New +$1.47M 0.19% 143
2020
Q4 		– Sell
-8,706
Closed -$1.43M – 198
2020
Q3 		$1.43M Buy
+8,706
New +$1.43M 0.45% 79

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Empowered Funds's MED Position: Q2 2026 in Review

Empowered Funds reduced its Medifast (MED) stake by 7.7% in Q2 2026, selling an estimated $63.2K and leaving 66,105 shares worth $701K. The position accounts for ﹤0.01% of the portfolio, ranked #1562.

Empowered Funds first reported a position in MED in Q3 2020 and has held it in 7 quarters since. The position peaked at $1.53M in Q2 2021. 113 funds tracked by Wall St. Rank hold MED as of Q2 2026.

  • Empowered Funds held 66,105 shares of Medifast worth $701K as of Q2 2026.
  • Empowered Funds sold 5,479 Medifast shares in Q2 2026, an estimated $63.2K.
  • Medifast made up ﹤0.01% of Empowered Funds's portfolio in Q2 2026, its #1562 holding.
  • Empowered Funds first reported a position in Medifast in Q3 2020 and has held it in 7 quarters since.
  • Empowered Funds's Medifast position peaked at $1.53M in Q2 2021.
  • 113 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.